Skip to main content

Corporate insider profile

Nicholas A.J. Botwood Insider Trades

Nicholas A.J. Botwood has reported no open-market purchases on SEC Form 4 and is a net seller of $1,183,640 across 1 company. The most recent open-market transaction was reported on Jun 12, 2026. Source: SEC Form 4 filings.

Latest reported as Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$1,183,639.85
Latest transaction
Jun 12, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 12, 2026Syndax Pharmaceuticals Inc (SNDX)Head of R&D, CMOSale65,515$18.07$1,183,640

Common questions

Nicholas A.J. Botwood insider trading FAQ

Is Nicholas A.J. Botwood buying or selling stock?
Across all SEC Form 4 open-market filings on record, Nicholas A.J. Botwood is a net seller of $1,183,640, with no open-market purchases reported. The latest transaction was reported on Jun 12, 2026.
Which companies does Nicholas A.J. Botwood report insider trades for?
Nicholas A.J. Botwood has reported open-market trades in Syndax Pharmaceuticals Inc (SNDX). The latest SEC-reported relationship is Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX).
Where does Nicholas A.J. Botwood's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 2066784, and refreshes this page daily.